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Result: Frequencies of malignant arrhythmia were significantly higher in Group 2 than in
Group 1 (62% vs 35%, p<0.05). Pericardial effusion and cardiac rupture were observed
more frequently in Group 2 than in Group 1 (62% vs 11%, P<0.001; 15% vs 0%,
p<0.001, respectively). All patients with cardiac rupture were observed in Group 2,
including one patient with subepicardial aneurysm and three with oozing rupture. Con-
gestive heart failure was observed more frequently in Group 2 than in Group 1 (46% vs
9%, p<0.001).
Conclusions: Even patients achieving TIMI grade 3 flow after PCI were often complicated
by malignant arrhythmia, pericardial effusion, and congestive heart failure if their CFV
patterns indicated severe microvascular injury. Thus, evaluation of CFV patterns immedi-
ately after PCI is clinically useful since they serve as predictors of the presence or
absence of complications, and in order to classify the severity of the patient’s condition in
the early stage.
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Background: Fractional flow reserve (FFR) is a measure of coronary stenosis severity
based on pressure measurements obtained at maximal hyperemia. Therefore, achieving
maximal vasodilatation is a prerequisite for determining FFR. All validation studies were
performed with intravenous adenosine (Ado-iv). However, compared to intracoronary
adenosine (Ado-ic), Ado-iv is more expensive, more time consuming and possibly asso-
ciated with more side effects. The present study was designed to compare high doses of
Ado-ic with Ado-iv.
Methods: 57 lesions (LAD,n=27; LCx, n=15; RCA, n=15) were studied in 54 pts. FFR was
assessed five times in every pt, with 4 bolus injections of Ado-ic (60, 90, 120 and 150 µg)
and standard Ado-iv (140µg/kg/min) in a randomized changing sequence.
Results: No adverse events occurred with Ado-ic injections into the LCA. Transient AV-
blocks were observed with Ado-ic into the RCA (4/15). With Ado-iv, minor side effects
(angina, dyspnoe) were noted in 21/54 pts (39%). Hemodynamics were not different.
Mean FFR was 0.79, 0.80, 0.78, 0.77 with 60 µg, 90 µg, 120 µg, 150 µg Ado-ic and 0.76
with Ado-iv. Focusing on the lowest absolute FFR value in every patient this was
achieved in 2% with the 60 µg dose, in 8% with 90 µg, in 20% with 120 µg, in 16% with
150 µg and in 62% with the intravenous application. With 60 µg of adenosine, 32% of
FFR values were below the cut-off point of 0.75. Higher doses increased this percentage
to 40%, 41%, 41%, and 46% for 90 µg, 120 µg, 150 µg, and the iv administration, respec-
tively.
Conclusions: This study suggests a dose-response relationship for intracoronary doses
higher than 60 µg. The administration of high intracoronary adenosine boluses is safe
and associated with fewer systemic side effects than standard intravenous adenosine.
However, intravenous adenosine with 140 µg/kg/min produced a more pronounced hype-
remia compared to intracoronary adenosine in the majority of patients and should thus
be the preferred mode of application for the assessment of FFR.
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The TFC has been proposed as a quantitative method to assess coronary blood flow.
This has been studied in the setting of an acute coronary syndrome. The effect of the
TFC on chronically diseased coronary arteries when film acquisition is made at 12.5f/s is
not available.
Aim: To determine the impact of coronary artery stenosis severity on the TFC in chroni-
cally stenosed coronary arteries when films are acquired at 12.5 f/s.
Methods: Coronary angiography was performed using 6F Judkins diagnostic catheters
after 200 micrograms of intracoronary nitrate acquired at 12.5 f/s. Analysis was per-
formed to obtain the mean TFC and the corrected TFC for <50% stenosis (group A), 50-
75% stenosis (group B) and >75% stenosis (group C). Results were corrected to give val-
ues equivalent to an acquisition rate of 30f/s. TIMI frame counting was performed by an
independent observer using the Philips Inturis Suite viewer R2.2.
Results are shown in tables 1. There was statistically significant difference in the TFC
between groups C & A and groups C & B: p=<0.01 and p=<0.01 for RCA; p=<0.01 and
<0.01 for CX; and p=<0.01 and <0.01 for LAD respectively. There was no significant dif-
ference in the TFC between groups A & B (p=0.1, 1.0 and 0.4 for RCA, CX and LAD
respectively).
Conclusion: We have demonstrated that there was a significant increase in the TFC
when the coronary artery stenosis was more than 75% reflecting significant flow abnor-
malities at this degree of stenosis in chronically diseased coronary arteries. 
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Background: Coronary flow velocity reserve (CFVR) measured with the Doppler flow
wire is commonly used to evaluate hemodynamic impairment of intermediate coronary
artery stenoses. The purpose of the present study was to investigate the diagnostic value
of Doppler flow velocity measurements in the evaluation of intermediate stenoses in
saphenous vein coronary artery bypass grafts and recipient vessels.
Methods: A total of 56 patients with a history of bypass surgery underwent coronary
angiography with Doppler velocity measurements before and after adenosine administra-
tion due to recurrent chest pain. Velocity was digitized to compute baseline and stress
average peak velocity (APV; cm/s), systolic peak velocity (SPV; cm/s), diastolic peak
velocity (DPV; cm/s), diastolic-to-systolic velocity ratio (DSVR) and CFVR. Quantitative
coronary arteriography was performed to objectively determine stenosis severity.
Results: Sixty-seven grafts had a luminal stenosis severity <50% (n=47) or 50-75%
(n=20). To determine diagnostic performances of each parameter in the identification of
intermediate stenoses (50-75%) in single grafts significant areas-under-the-curve in
receiver operating characteristic analysis were found for DPVbaseline, APVstress, SPVstress
and DPVstress (p<0.05). In sequential grafts significant areas-under-the-curve were dem-
onstrated for APVstress and DPVstress (p<0.05). CFVR did not show significance in sepa-
rating grafts with stenoses <50% and 50-75% for single or sequential grafts. In
multivariate analysis sensitivity/specificity/diagnostic accuracy of velocity parameters for
the identification of intermediate stenoses were 92%/72%/78% for single grafts and
100%/73%/82% for sequential grafts.
Conclusion: Doppler velocity accurately identifies intermediate stenoses by differentiat-
ing between <50% and 50-75% stenosis in both single and sequential vein grafts and
recipient vessels. Doppler velocity measurements have additional diagnostic value in
evaluating intermediate stenoses in vein grafts and recipient vessels.
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Background: Some studies have shown that the no-reflow phenomenon after coronary
reflow implies the absence of residual infarct-zone viability. Furthermore, it has been
reported that the coronary flow velocity (CFV) pattern of no-reflow in patients with reper-
fused acute myocardial infarction (AMI) is characterized by the appearance of early sys-
tolic retrograde flow and short diastolic deceleration time (DDT). However, the
relationship between CFV pattern and residual myocardial viability has not been dis-
cussed. The aim of this prospective study was to examine whether the CFV pattern may
predict myocardial viability at the late stage.
Methods: The study population consisted of 113 consecutive patients with a first anterior
AMI successfully treated with percutaneous coronary intervention (<50% residual steno-
sis). We examined the CFV pattern immediately after coronary intervention using a Dop-
Table 1
TFC – Diseased RCA in elective coronary angiography [Mean ± SD]
RCA Group A <50% Group B 50-75% Group C >75%
Number 41 22 18
Reference diameter 3.3 ± 1.1 3.4 ± 1 3 ± 0.8
TFC 8 ± 2 9.4 ± 5 31 ± 21
cTFC 19 ± 4 22.8 ± 13 75 ± 52
TFC – Diseased CX in elective coronary angiography [Mean ± SD]
CX Group A <50% Group B 50-75% Group C >75%
Number 35 21 23
Reference diameter 3.5 ± 0.8 3.3 ± 0.7 2.8 ± 0.5
TFC 12 ± 4 12.3 ± 3.9 20 ± 11
cTFC 29 ± 9 30 ± 9 49 ± 25
TFC – Diseased LAD in elective coronary angiography [Mean ± SD]
LAD Group <50% Group B 50-75% Group C >75%
Number 39 31 34
Reference diameter 3.3 ± 0.7 3.4 ± 0.8 3 ± 0.7
TFC 17 ± 8 16.5 ± 7 24 ± 12
cTFC 28 ± 12 26 ± 11 38 ± 19
